New diagnostic tool of tuberculosis: Interferon-gamma assays;Tüberküloz tanisinda yeni bir yöntem: İnterferon-gama araştirmasina dayanan testler

Tuberkuloz ve Toraks

Volumn 55, Issue 1, 2007, Pages 108-117

  Çelik, Ümit ^a   Kocabaş, Emine ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Interferon gamma assay; Tuberculin skin test; Tuberculosis

Indexed keywords

GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN;

CELL ASSAY; DIAGNOSTIC TEST; HUMAN; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PROTEIN DETERMINATION; REVIEW; T LYMPHOCYTE; TUBERCULIN TEST;

HUMANS; INTERFERON TYPE II; PREDICTIVE VALUE OF TESTS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 34249275358     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993; 17: 968-75.
2. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356: 1099-104.
3. Jasmer RM, Nahid P, Hopewell PC. Clinical practice. Latent tuberculosis infection. N Engl J Med 2002; 347: 1860-66.
4. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000; 161: 1376-95.
5. Ferebee SH. Controlled chemoprophlyazis trials in tuberculosis. A general review. Bibl Tuberc 1970; 26: 28-106.
6. Tufariello JM, Chan J, Flynn JL. Latent tuberculosis: Mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis 2003; 3: 578-90.
7. Styblo K. Recent advances in epidemiological research in tuberculosis. Adv Tuberc Res 1980; 20: 1-63.
8. Mandalakas AM, Starke JR. Current concept of childhood tuberculosis. Semin Pediatr Infect Dis 2005; 16: 93-104.
9. Pai M, Riley LW, Colford JM. Interferon gamma assays in the immunodiagnosis of tuberculosis: A systematic review. Lancet Infect Dis 2004; 4: 761-76.
10. Dockrell HM, Weir RE. Whole blood cytokine assays-a new generation of diagnostic tests for tuberculosis? Int J Tuberc Lung Dis 1998; 2: 441-2.
11. Lalvani A. Spotting latent infection: The path to better tuberculosis control. Thorax 2003; 58: 916-8.
12. Lein AD, Von Reyn CF. In vitro cellular and cytokine responses to mycobacterial antigens: Application to diagnosis of tuberculosis infection and assessment of response to mycobacterial vaccines. Am J Med Sci 1997; 313: 364-71.
13. Sorensen AL, Nagai S, Houen G, et al. Purification and characterization of a tow-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 1995; 63: 1710-7.
14. Mazurek GH, Villarino ME. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003; 52: 15-8.
15. Mazurek GH, Jereb J, Lobue P. Guidelines for using the QuantiFERON TB Gold test for detecting Mycobacterium tuberculosis Infection, United States. MMWR Recomm Rep 2005; 54: 49-55.
16. Arend SM, Andersen P, van Meijgaarden KE, et al. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. J Infect Dis 2000; 181: 1850-4.
17. Brock I, Munk ME, Kok-Jensen A, Andersen P. Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis 2001; 5: 462-7.
18. Brock I, Weldingh K, Leyten EM, et al. Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. J Clin Microbiol 2004; 42: 2379-87.
19. Chapman AL, Munkanta M, Wilkinson KA, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by numeration of Mycobacterium tuberculosis-specific T cells. AIDS 2002; 16: 2285-93.
20. Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection: An interferon gamma-based assay using new antigens. Am J Respir Crit Care Med 2004; 170: 59-64.
21. Munk ME, Arend SM, Brock I, et al. Use of ESAT-6 and CFP-10 antigens for diagnosis of extrapulmonary tuberculosis. J Infect Dis 2001; 183: 175-6.
22. Ravn P, Munk ME, Andersen AB. The diagnostic potential of the QuantiFERON-RD1 test in patients with active tuberculosis. Abstract O411. Clin Microbiol Infect 2004; 10: 80.
23. Scarpellini P, Tasca S, Galli L, et al. Selected pool of peptides from ESAT-6 and CFP-10 proteins for detection of Mycobacterium tuberculosis infection. J Clin Microbiol 2004; 42: 3469-74.
24. Van Pinxteren LA, Ravn P, Agger EM, et al. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol 2000; 7: 155-60.
25. Lein AD, von Reyn CF, Ravn P, et al. Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis. Clin Diagn Lab Immunol 1999; 6: 606-9.
26. Mazurek GH, LoBue PA, Daley CL, et al. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001; 286: 1740-7.
27. Pottumarthy S, Morris AJ, Harrison AC, Wells VC. Evaluation of the tuberculin gamma interferon assay: Potential to replace the Mantoux skin test. J Clin Microbiol 1999; 37: 3229-32.
28. Elliott AM, Hurst TJ, Balyeku MN, et al. The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: Application of a whole blood cytokine assay in an epidemiological study. Int J Tuberc Lung Dis 1999; 3: 239-47.
29. Lalvani A, Pathan AA, McShane H, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 2001; 163: 824-8.
30. Brock I, Munk ME, Kok-Jensen A, Andersen P. Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis 2001; 5: 462-7.
31. Lalvani A, Pathan AA, McShane H, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 2001; 163: 824-8.
32. Ravn P, Demissie A, Eguale T, et al. Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J Infect Dis 1999; 179: 637-45.
33. Vekemans J, Lienhardt C, Sillah JS, et al. Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun 2001; 69: 6554-7.
34. Vekemans J, Ota MO, Sillah J, et al. Immune responses to mycobacterial antigens in the Gambian population: Implications for vaccines and immunodiagnostic test design. Infect Immun 2004; 72: 381-8.
35. Fietta A, Meloni F, Cascina A, et al. Comparison of a whole-blood interferon-gamma assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection. Am J Infect Control 2003; 31: 347-53.
36. Ewer K, Deeks J, Alvarez L, et al. Comparison of T cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361: 1168-73.
37. Brock I, Weldingh K, Lillebaek T, et al. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 2004; 170: 65-9.
38. Hill PC, Brookes RH, Fox A, et al. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis 2004; 38: 966-73.
39. Richeldi L, Ewer K, Losi M, Bergamini BM, et al. T cell-based tracking of multidrug resistant tuberculosis infection alter brief exposure. Am J Respir Crit Care Med 2004; 170: 288-95.
40. Johnson PD, Stuart RL, Grayson ML, et al. Tuberculin-purified protein derivative-, MPT-64, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol 1999; 6: 934-7.
41. Diel R, Nienhaus A, Lange C, et al. Tuberculosis contact investigation with a new spesific blood testin low incidence population containing a high proportion of BCG vaccinated persons. Respiratory Research 2006; 17: 77.
42. Doherty TM, Demissie A, Olobo J, et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 2002; 40: 704-6.
43. Carrara S, Vincenti D, Petrosillo N, et al. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 2004; 38: 754-6.
44. Lalvani A, Pathan AA, Durkan H, et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 2001; 357: 2017-21.
45. Pathan AA, Wilkinson KA, Klenerman P, et al. Direct ex vivo analysis of antigen-specific IFN-gamma secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 2001; 167: 5217-25.
46. Ulrichs T, Anding R, Kaufmann SH, Munk ME. Numbers of IFN-gamma-producing cells against ESAT-6 increase in tuberculosis patients during chemotherapy. Int J Tuberc Lung Dis 2000; 4: 1181-3.
47. Wu-Hsieh BA, Chen CK, Chang JH, et al. Long-lived immune response to early secretory antigenic target 6 in individuals who had recovered from tuberculosis. Clin Infect Dis 2001; 33: 1336-40.
48. Hirsch CS, Toossi Z, Othieno C, et al. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: Analysis of underlying mechanisms and modulation with therapy. J Infect Dis 1999; 180: 2069-73.
49. Aiken A, Hill P, Fox A, et al. Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis 2006; 6: 2334-46.
50. Pai M, Joshi R, Dogra S, et al. Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: A preliminary report. J Occup Med Toxicol 2006; 23: 1-7.
51. Richeldi L, Ewer K, Losi M, et al. Repeated tuberculin testing does not induce false positive ELISPOT results. Thorax 2006; 6: 180.
52. Ferrara G, Losi M, D'Amico R, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: A prospective study. Lancet 2006; 367: 1328-34.
53. Ferrera G, Losi M, Meacci M, et al. Routine hospital use of a new commercial whole blood interferon gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2005; 172: 631-5.
54. Brock I, Ruhwald M, Lundgren B, et al. Latent tuberculosis in HIV positive diagnosed by the M. tuberculosis spesific interferon gamma test. Respir Res 2006; 7: 56.
55. Meier T, Eulenbruch HP, Wringhton-Smith P, et al. Sensitivity of a new commercial enzyme linked immunospot assay (T SPOT TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis 2005; 24: 529-36.
56. Shams H, Weis SE, Klucar P, et al. Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med 2005; 172: 1161-8.
57. Zellweger JP, Zellweger A, Ansermet S, et al. New T cell based test correlates better with tuberculosis exposure than tuberculin skin test. Int J Tuberc Lung Dis 2005; 9: 1242-7.
58. Ravn P, Munk ME, Andersen AB, et al. Prospective evaluation of a whole blood test using Mycobacterium tuberculosis spesific antigens ESAT 6 and CFP10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol 2005; 12: 491-6.
59. Dheda K, Lalvani A, Miller RF, et al. Performance of a T cell based diagnostic for tuberculosis infection in HIV infected individuals is independent of CD4 cell count. AIDS 2005; 19: 2038-41.